Search

Your search keyword '"McDonell, Michael"' showing total 582 results
Start Over Author "McDonell, Michael"
582 results on '"McDonell, Michael"'

104. Proximity to Screening Site, Rurality, and Neighborhood Disadvantage: Treatment Status among Individuals with Sexually Transmitted Infections in Yakima County, Washington

Author

Amiri, Solmaz, primary, Pham, Christine D., additional, Amram, Ofer, additional, Alcover, Karl C., additional, Oluwoye, Oladunni, additional, Bravo, Lilian, additional, Sixberry, Melissa, additional, McDonell, Michael G., additional, Roll, John M, additional, and Fresco, Andre, additional

Published
2020
Full Text
View/download PDF

105. Preliminary Evaluation of Washington State’s Early Intervention Program for First-Episode Psychosis

Author

Oluwoye, Oladunni, primary, Reneau, Hailey, additional, Stokes, Bryony, additional, Daughtry, Rebecca, additional, Venuto, Elizabeth, additional, Sunbury, Tenaya, additional, Hong, Grace, additional, Lucenko, Barbara, additional, Stiles, Bryan, additional, McPherson, Sterling M., additional, Kopelovich, Sarah, additional, Monroe-DeVita, Maria, additional, and McDonell, Michael G., additional

Published
2020
Full Text
View/download PDF

106. HIV and syphilis infections and associated factors among patients in treatment at a Specialist Alcohol, Tobacco, and Drugs Center in São Paulo’s “Cracolândia”

Author

Ribeiro, Ariadne, primary, Trevizol, Alisson, additional, Oluwoye, Oladunni, additional, McPherson, Sterling, additional, McDonell, Michael G., additional, Briese, Viviane, additional, Miguel, André C., additional, Fratzinger, Rosana C., additional, Laranjeira, Ronaldo R., additional, Alonso, Ana L., additional, Karasin, Ana L., additional, Ribeiro, Marcelo, additional, and Madruga, Clarice S., additional

Published
2020
Full Text
View/download PDF

111. Cannabis use and metabolic syndrome among clients with first episode psychosis.

Author

Stiles, Erik, Alcover, Karl C., Stiles, Bryan, Oluwoye, Oladunni, and McDonell, Michael G.

Subjects
METABOLIC syndrome, MARIJUANA, HIGH density lipoproteins, PSYCHOSES, LOGISTIC regression analysis
Abstract

Aim: To explore the relationship between cannabis use and metabolic syndrome (MetS) among those who have experienced first episode psychosis (FEP). Methods: A retrospective analysis of 404 participants enrolled in the Recovery After Initial Schizophrenia Episode‐Early Treatment Program (RAISE‐ETP) was conducted. Using multiple logistic regression, we investigated the correlation between cannabis use and rate of MetS at baseline and across time as well as the specific metabolic derangements among cannabis users and abstainers. Results: Although cannabis users had similar rates of MetS at baseline when compared with abstainers, those who used cannabis at any time during the study period tended to have lower triglycerides and elevated high‐density lipoprotein (HDL). Cannabis users were less likely to develop MetS, relative to nonusers. Conclusions: Cannabis use may be associated with lower incidence of MetS in patients who have experienced FEP. Further research is indicated to develop these observations. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

112. A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies

Author

McPherson,Sterling, Burduli,Ekaterina, Smith,Crystal, Herron,Jalene, Oluwoye,Oladunni, Hirchak,Katherine, Orr,Michael, McDonell,Michael, and Roll,John

Subjects
Substance Abuse and Rehabilitation
Abstract

Sterling M McPherson,1–4 Ekaterina Burduli,1–5 Crystal Lederhos Smith,1–4 Jalene Herron,2,6 Oladunni Oluwoye,2,6 Katherine Hirchak,2–4 Michael F Orr,1–5 Michael G McDonell,1–5 John M Roll1–5 1Department of Medical Education and Clinical Sciences, Elson S Floyd College of Medicine, Washington State University, 2Programs of Excellence in Addictions Research, Washington State University, 3Analytics and Psychopharmacology Laboratory (APPL), Washington State University, 4Translational Addictions Research Center, Washington State University, 5College of Nursing, Washington State University, 6Behavioral Health Interventions (BHI), Washington State University, Spokane,WA, USA Abstract: This review of contingency management (CM; the behavior-modification method of providing reinforcement in exchange for objective evidence of a desired behavior) for the treatment of substance-use disorders (SUDs) begins by describing the origins of CM and how it has come to be most commonly used during the treatment of SUDs. Our core objective is to review, describe, and discuss three ongoing critical advancements in CM. We review key emerging areas wherein CM will likely have an impact. In total, we qualitatively reviewed 31 studies in a systematic fashion after searching PubMed and Google Scholar. We then describe and highlight CM investigations across three broad themes: adapting CM for underserved populations, CM with experimental technologies, and optimizing CM for personalized interventions. Technological innovations that allow for mobile delivery of reinforcers in exchange for objective evidence of a desired behavior will likely expand the possible applications of CM throughout the SUD-treatment domain and into therapeutically related areas (eg, serious mental illness). When this mobile technology is coupled with new, easy-to-utilize biomarkers, the adaptation for individual goal setting and delivery of CM-based SUD treatment in hard-to-reach places (eg, rural locations) can have a sustained impact on communities most affected by these disorders. In conclusion, there is still much to be done, not only technologically but also in convincing policy makers to adopt this well-established, cost-effective, and evidence-based method of behavior modification. Keywords: contingency management, novel substance-use treatment technologies, drug- and alcohol-use biomarkers, substance-use disorder treatment

Published
2018

113. Contingency Management Is a Powerful Clinical Tool for Treating Substance Use: Research Evidence and New Practice Guidelines for Use.

Author

McPherson, Sterling M., Parent, Sara, Miguel, André, and McDonell, Michael

Subjects
SUBSTANCE abuse treatment, MEDICAL protocols, HUMAN services programs, TREATMENT effectiveness, REWARD (Psychology), BEHAVIOR modification
Abstract

The article presents research evidence and new practice guidelines for use of contingency management (CM), an effective behavior change technique commonly used to treat substance use disorders (SUD). Topics covered include a brief background and rationale of CM-based treatments for SUD, the challenges in the implementation of CM in clinical care, and guidance to clinicians hoping to implement CM based on lessons learned from the U.S. Veterans Administration CM program.

Published
2022

121. Effect of Incentives for Alcohol Abstinence in Partnership With 3 American Indian and Alaska Native Communities: A Randomized Clinical Trial.

Author

McDonell, Michael G., Hirchak, Katherine A., Herron, Jalene, Lyons, Abram J., Alcover, Karl C., Shaw, Jennifer, Kordas, Gordon, Dirks, Lisa G., Jansen, Kelley, Avey, Jaedon, Lillie, Kate, Donovan, Dennis, McPherson, Sterling M., Dillard, Denise, Ries, Richard, Roll, John, Buchwald, Dedra, and HONOR Study Team

Subjects
TEMPERANCE movement in the United States, ALASKA Natives, CLINICAL trials, INCENTIVE (Psychology), ADULTS
Abstract

Importance: Many American Indian and Alaska Native communities are disproportionately affected by problems with alcohol use and seek culturally appropriate and effective interventions for individuals with alcohol use disorders.Objective: To determine whether a culturally tailored contingency management intervention, in which incentives were offered for biologically verified alcohol abstinence, resulted in increased abstinence among American Indian and Alaska Native adults. This study hypothesized that adults assigned to receive a contingency management intervention would have higher levels of alcohol abstinence than those assigned to the control condition.Design, Setting, and Participants: This multisite randomized clinical trial, the Helping Our Native Ongoing Recovery (HONOR) study, included a 1-month observation period before randomization and a 3-month intervention period. The study was conducted at 3 American Indian and Alaska Native health care organizations located in Alaska, the Pacific Northwest, and the Northern Plains from October 10, 2014, to September 2, 2019. Recruitment occurred between October 10, 2014, and February 20, 2019. Eligible participants were American Indian or Alaska Native adults who had 1 or more days of high alcohol-use episodes within the last 30 days and a current diagnosis of alcohol dependence. Data were analyzed from February 1 to April 29, 2020.Interventions: Participants received treatment as usual and were randomized to either the contingency management group, in which individuals received 12 weeks of incentives for submitting a urine sample indicating alcohol abstinence, or the control group, in which individuals received 12 weeks of incentives for submitting a urine sample without the requirement of alcohol abstinence. Regression models fit with generalized estimating equations were used to assess differences in abstinence during the intervention period.Main Outcomes and Measures: Alcohol-negative ethyl glucuronide (EtG) urine test result (defined as EtG<150 ng/mL).Results: Among 1003 adults screened for eligibility, 400 individuals met the initial criteria. Of those, 158 individuals (39.5%; mean [SD] age, 42.1 [11.4] years; 83 men [52.5%]) met the criteria for randomization, which required submission of 4 or more urine samples and 1 alcohol-positive urine test result during the observation period before randomization. A total of 75 participants (47.5%) were randomized to the contingency management group, and 83 participants (52.5%) were randomized to the control group. At 16 weeks, the number who submitted an alcohol-negative urine sample was 19 (59.4%) in the intervention group vs 18 (38.3%) in the control group. Participants randomized to the contingency management group had a higher likelihood of submitting an alcohol-negative urine sample (averaged over time) compared with those randomized to the control group (odds ratio, 1.70; 95% CI, 1.05-2.76; P = .03).Conclusions and Relevance: The study's findings indicate that contingency management may be an effective strategy for increasing alcohol abstinence and a tool that can be used by American Indian and Alaska Native communities for the treatment of individuals with alcohol use disorders.Trial Registration: ClinicalTrials.gov Identifier: NCT02174315. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

123. Predictors of tobacco and alcohol co-use from ages 15 to 32: The Amsterdam Growth and Health Longitudinal Study.

Author

McPherson, Sterling M., primary, Burduli, Ekaterina, additional, Smith, Crystal Lederhos, additional, Brooks, Olivia, additional, Orr, Michael F., additional, Barbosa-Leiker, Celestina, additional, Hoekstra, Trynke, additional, McDonell, Michael G., additional, Murphy, Sean M., additional, Layton, Matthew, additional, and Roll, John M., additional

Published
2018
Full Text
View/download PDF

127. Contingency management intervention targeting co-addiction of alcohol and drugs among American Indian adults: Design, methodology, and baseline data

Author

Burduli, Ekaterina, primary, Skalisky, Jordan, additional, Hirchak, Katherine, additional, Orr, Michael F, additional, Foote, Albert, additional, Granbois, Alexandria, additional, Ries, Richard, additional, Roll, John M, additional, Buchwald, Dedra, additional, McDonell, Michael G, additional, and McPherson, Sterling M, additional

Published
2018
Full Text
View/download PDF

128. Focus groups to increase the cultural acceptability of a contingency management intervention for American Indian and Alaska Native Communities

Author

Hirchak, Katherine A., primary, Leickly, Emily, additional, Herron, Jalene, additional, Shaw, Jennifer, additional, Skalisky, Jordan, additional, Dirks, Lisa G., additional, Avey, Jaedon P., additional, McPherson, Sterling, additional, Nepom, Jenny, additional, Donovan, Dennis, additional, Buchwald, Dedra, additional, and McDonell, Michael G., additional

Published
2018
Full Text
View/download PDF

130. Sociodemographic Characteristics, Patterns of Crack Use, Concomitant Substance Use Disorders, and Psychiatric Symptomatology in Treatment-Seeking Crack-Dependent Individuals in Brazil

Author

Miguel, André Q. C., primary, Madruga, Clarice S., additional, Cogo-Moreira, Hugo, additional, Yamauchi, Rodolfo, additional, Simões, Viviane, additional, Da Silva, Claudio J., additional, Abdalla, Renata R., additional, McDonell, Michael, additional, McPherson, Sterling, additional, Roll, John M., additional, Mari, Jair J., additional, and Laranjeira, Ronaldo R., additional

Published
2018
Full Text
View/download PDF

137. A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness

Author

McDonell, Michael G., primary, Leickly, Emily, additional, McPherson, Sterling, additional, Skalisky, Jordan, additional, Srebnik, Debra, additional, Angelo, Frank, additional, Vilardaga, Roger, additional, Nepom, Jenny R., additional, Roll, John M., additional, and Ries, Richard K., additional

Published
2017
Full Text
View/download PDF

138. M131. Washington State New Journeys Program for Young Adults Experiencing First Episode Psychosis: Pilot Results

Author

Leickly, Emily, primary, McDonell, Michael, additional, Monroe-DeVita, Maria, additional, Peterson, Roselyn, additional, Oluwoye, Oladunni, additional, Hughes, MacKenzie, additional, Blajeski, Shannon, additional, Roskelley, Jeffery, additional, Kopelovich, Sarah, additional, Moore, Christopher, additional, and Blair, Todd, additional

Published
2017
Full Text
View/download PDF

144. Spatial access to opioid treatment program and alcohol and cannabis outlets: analysis of missed doses of methadone during the first, second, and third 90 days of treatment.

Author

Amiri, Solmaz, Lutz, Robert B., McDonell, Michael G., Roll, John M., and Amram, Ofer

Subjects
TREATMENT programs, METHADONE hydrochloride, MARIJUANA, ALCOHOL
Abstract

Background: The burden of access to opioid treatment programs (OTPs) may change as clients become eligible for take-home privileges. Our previous study showed clients who lived more than 10-miles away from an OTP were more likely to miss methadone doses during the first 30 days of treatment. Proximity to alcohol and cannabis outlets may also negatively influence treatment adherence.Objective: To examine the association between access to this OTP, alcohol and cannabis outlets, and the number of missed methadone doses during the first, second, and third 90 days of treatment.Methods: The number of missed methadone doses was calculated for 752, 689, and 584 clients who remained in treatment, respectively, for at least 3, 6, and 9 months (50% female). Distance between client's home and the OTP, alcohol, and cannabis outlets was measured. Generalized linear models were employed.Results: Shorter distance from a client's residence to the OTP was associated with a decreased number of missed methadone doses during the first 90 days of treatment. Shorter distance to the closest cannabis retail outlet was associated with an increased number of missed methadone doses during the first and second 90 days of treatment. Shorter distance to the closest off-premise alcohol outlet was associated with an increased number of missed methadone doses during the third 90 days of treatment.Conclusions: Improving spatial accessibility of OTPs are essential to ensure treatment opportunities are available for individuals so affected. Exploring to what extent residing in areas that facilitate alcohol and cannabis availability can influence treatment adherence is warranted. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

145. Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: Data from the national RAISE‐ETP study.

Author

Oluwoye, Oladunni, Burduli, Ekaterina, McDonell, Michael G., McPherson, Sterling, Monroe‐DeVita, Maria, Chwastiak, Lydia, and McClellan, Jon M.

Subjects
CANNABIS (Genus), HEALTH outcome assessment, PSYCHOSES, SCHIZOPHRENIA, TOBACCO
Abstract

Aim: The primary aim of this study was to examine the effect of recent tobacco, alcohol and cannabis use on treatment outcomes among participants experiencing first episode psychosis (FEP). Methods: Secondary data analyses were conducted on 404 participants enrolled in the Recovery After an Initial Schizophrenia Episode—Early Treatment Program (RAISE‐ETP) study. RAISE‐ETP investigated the effectiveness of a coordinated specialty care (CSC) intervention for FEP in community mental health agencies in the United States. Generalized estimating equations were used to examine whether recent tobacco smoking, alcohol, and cannabis use at baseline were associated with illness severity, number of antipsychotic pills missed, psychiatric symptoms and quality of life during the 24‐month treatment period, after controlling for duration of untreated psychosis and treatment group. Results: At baseline, roughly 50% (n = 209) of participants reported recent tobacco, 28% (n = 113) alcohol and 24% (n = 95) cannabis use. Tobacco smokers had higher levels of illness severity (β =.24; P <.005), a higher number of missed pills (β = 2.89; P <.05), higher psychiatric symptoms and lower quality of life during treatment relative to non‐smokers. Alcohol users had a higher number of missed pills (β = 3.16; P <.05) during treatment and cannabis users had higher levels of illness severity (β =.18; P <.05) and positive symptoms (β = 1.56; P <.05) relative to non‐users. Conclusions: Tobacco, alcohol and cannabis use are common in youth seeking treatment for FEP. Tobacco smoking was associated with more negative clinical outcomes. These findings have implications for including interventions targeting these areas of substance use within current CSC models. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results